Clasado has announced that its Bimuno® consumer supplement range has been acquired by ELEAT, a challenger brand in the health and nutrition sector. This strategic move enables Clasado to focus exclusively on its core B2B prebiotic ingredients business.
The acquisition encompasses the Bimuno finished supplement product line and customer base, as well licence rights to continue the commercialisation of a consumer product containing Bimuno® GOS as its sole active ingredient in the UK. Clasado retains full ownership of Bimuno GOS, its proprietary galactooligosaccharide prebiotic ingredient, which will continue to be available to formulators and health brands globally. The Bimuno supplement range has built a strong reputation with consumers, achieving an average 4.5-star rating from over 3,900 reviews on Trustpilot, with 94% of customers reporting improved digestion and overall gut health as highlighted in a customer satisfaction survey (2024).
Per Rehné, CEO of Clasado Biosciences, commented: “The divestment of our finished consumer product range represents an exciting new chapter for Clasado. Stepping away from the direct to consumer market enables us to focus on our core strengths, and dedicate all our efforts to providing our multi award-winning prebiotic functional ingredient to brands around the world. With gut health becoming increasingly important on the global stage, our team is fully committed to building on the success and demand for science-backed biotics via our branded ingredient, Bimuno GOS.”
The move comes at a time when consumer interest in gut health is soaring. According to recent McKinsey research across Asia, Europe and North America, more than 80 percent of consumers consider gut health to be important. What’s more, over 50 percent of consumers expect it to be higher priority for them in the next two to three years. This growing demand positions Clasado to accelerate the global expansion of its ingredient business, supporting formulators and manufacturers with scientifically validated prebiotic solutions.
Hywel Rose, Co-founder at ELEAT, stated: “As a breakthrough brand in the healthy breakfast space, we’re focused on helping people eat well and move well and this acquisition supports our goal to grow in the health and nutrition category. The Bimuno supplement range is an ideal fit for us being established and scientifically backed. The acquisition represents our commitment to supporting health and wellbeing in a convenient way, as well as diversifying our product portfolio to accelerate growth. We see tremendous potential for health to take centre stage when it comes to performance in the UK market, and we’re excited about the opportunity to take Bimuno forward, reaching more and more people.”
The Bimuno supplement range will over time transition into the ELEAT brand architecture, while Clasado continues to expand its global presence as a leading provider of scientifically validated prebiotic ingredients to formulators and manufacturers worldwide.
For more information about Clasado click here.
